NCT07062016View on ClinicalTrials.gov

Molecular and ctDNA Characterization of High-Risk Endometrial Cancer

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

October 31, 2028

Study Completion Date

October 31, 2028

Conditions
Endometrial CarcinomaEndometrial High Grade Endometrioid AdenocarcinomaStage II Endometrial CancerStage III Endometrial CancerStage IV Endometrial Cancer
Interventions
OTHER

Non-Interventional Study

Non-interventional study

Trial Locations (1)

55905

RECRUITING

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER